Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Qutenza

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Objectives:Qutenza is a high-dose capsaicin patch used to relieve neuropathic pain from postherpetic neuralgia (PHN) and HIV… Expand
2014
2014
Introduction:Qutenza (capsaicin) 8% patch is used to treat various neuropathic indications, including postherpetic neuralgia (PHN… Expand
Highly Cited
2013
Highly Cited
2013
Summary Qutenza is effective for the treatment of both postherpetic neuralgia and human immunodeficiency virus‐associated… Expand
  • table 1
  • table 2
  • table 3
  • figure 1
  • figure 2
2013
2013
Treatment of chronic pain conditions is commonly assessed at specific endpoints at preset times during or after treatment by… Expand
2013
2013
Qutenza is a high potency capsaicin topical patch which has been recommended for the treatment of peripheral neuropathic pain… Expand
2012
2012
The diagnosis and the management of neuropathic pain still remain challenging. The main reason for these is the variety of… Expand
2011
2011
  • The Medical letter on drugs and therapeutics
  • 2011
  • Corpus ID: 9055297
The FDA has approved a topical 8% patch formulation of capsaicin (Qutenza-NeurogesX), available only by prescription, for local… Expand
Review
2011
Review
2011
ABSTRACT Qutenza is a high-potency capsaicin (8%) topical patch, labeled for treating pain associated with postherpetic neuralgia… Expand
2010
2010
Patients recorded their ‘average pain for the past 24 hours’ using the Numeric Pain Rating Scale (NPRS) daily. The proportion of… Expand